Insomnia is characterized by difficulty in falling asleep, daytime sleepiness, and an excessively earlier wake-up time than desired, resulting in unsatisfactory sleep quality and quantity [1,2]. Insomnia reduces the function and quality of life during the daytime and increases the risk of physical and mental illness, which can result in social and occupational difficulty and disability [3]. Current medications for insomnia include benzodiazepine receptor agonists, antihistamines, tricyclic antidepressants, and melatonin receptor agonists. However, they are associated with side effects including drowsiness, dizziness, and impaired cognitive function, especially in elderly populations. Therefore, medication use for insomnia requires special attention [4,5]. In addition, nonpharmacological treatment, such as stimulant control therapy, relaxation training, and cognitive behavioral therapy, are often difficult to perform in everyday medical environments because skilled sleep specialists are needed [6]. Even with known pharmacological and non-pharmacological therapies, approximately 30% of paTherapeutic Application of Transcutaneous Auricular Vagus Nerve Stimulation in Primary Insomnia
Therapeutic Application of Transcutaneous Auricular Vagus Nerve Stimulation in Primary Insomnia
Published 2019 in Chronobiology in Medicine
ABSTRACT
PUBLICATION RECORD
- Publication year
2019
- Venue
Chronobiology in Medicine
- Publication date
2019-06-30
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-34 of 34 references · Page 1 of 1
CITED BY
Showing 1-5 of 5 citing papers · Page 1 of 1